MCM
EW icon

Maple Capital Management’s Edwards Lifesciences EW Stock Holding History

Maple Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399K Buy
4,980
+1,130
+29% +$93.2K 0.03% 83
2025
Q4 		$328K Hold
3,850
– – 0.02% 95
2025
Q3 		$299K Hold
3,850
– – 0.02% 95
2025
Q2 		$301K Sell
3,850
-2
-0.1% -$149 0.02% 97
2025
Q1 		$279K Buy
3,852
+277
+8% +$19.8K 0.02% 98
2024
Q4 		$265K Sell
3,575
-58
-2% -$4.06K 0.02% 98
2024
Q3 		$240K Buy
3,633
+58
+2% +$4.21K 0.02% 102
2024
Q2 		$330K Hold
3,575
– – 0.03% 96
2024
Q1 		$342K Buy
3,575
+428
+14% +$36K 0.03% 86
2023
Q4 		$240K Buy
3,147
+11
+0.4% +$765 0.02% 92
2023
Q3 		$217K Buy
3,136
+11
+0.4% +$884 0.02% 93
2023
Q2 		$295K Hold
3,125
– – 0.03% 83
2023
Q1 		$259K Buy
3,125
+332
+12% +$26.1K 0.03% 83
2022
Q4 		$208K Buy
2,793
+45
+2% +$3.47K 0.03% 91
2022
Q3 		$202K Buy
2,748
+18
+0.7% +$1.73K 0.03% 91
2022
Q2 		$260K Hold
2,730
– – 0.03% 81
2022
Q1 		$321K Buy
2,730
+923
+51% +$104K 0.04% 83
2021
Q4 		$234K Buy
+1,807
New +$211K 0.03% 100

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maple Capital Management's EW Position: Q1 2026 in Review

Maple Capital Management increased its Edwards Lifesciences (EW) stake by 29% in Q1 2026, buying an estimated $93.2K and bringing the position to 4,980 shares worth $399K. The position accounts for 0.03% of the portfolio, ranked #83.

Maple Capital Management first reported a position in EW in Q4 2021 and has held it in 18 quarters since. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Maple Capital Management held 4,980 shares of Edwards Lifesciences worth $399K as of Q1 2026.
  • Maple Capital Management bought 1,130 Edwards Lifesciences shares in Q1 2026, an estimated $93.2K.
  • Edwards Lifesciences made up 0.03% of Maple Capital Management's portfolio in Q1 2026, its #83 holding.
  • Maple Capital Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.